跳至主要内容
临床试验/NCT02361944
NCT02361944已完成2 期

Risk of Oxygen During Cardiac Surgery (ROCS) Trial

Vanderbilt University1 个研究点 分布在 1 个国家目标入组 213 人开始时间: 2016年4月5日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
213
试验地点
1
主要终点
Intraoperative Systemic Oxidative Damage

研究概览

简要总结

The investigators will recruit and randomize 200 elective cardiac surgery patients to receive physiologic oxygenation (normoxia) or hyper-oxygenation (hyperoxia) during surgery to test the hypothesis that intraoperative physiologic oxygenation decreases the generation of reactive oxygen species, oxidative damage, and postoperative organ injury compared to hyper-oxygenation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Open-heart cardiac surgery, defined as surgery on the heart or aorta that requires sternotomy or thoracotomy.

排除标准

  • Current acute coronary syndrome (defined as ST elevation myocardial infarction or non-ST elevation myocardial infarction (troponin leak within 72 hours of surgery or consent +/- EKG changes consistent with myocardial ischemia)).
  • Home supplemental oxygen use.
  • Preoperative supplemental oxygen requirement to maintain arterial O2 sat of 92%.
  • Right to left intracardiac shunt including atrial septal defect and ventricular septal defect with Cor Pulmonale.
  • Carotid stenosis defined as >50% stenosis.
  • Cardiac surgery that requires intraoperative circulatory arrest, such as aortic arch replacement.
  • Current use of hemo- or peritoneal dialysis.
  • Pregnancy

研究组 & 干预措施

Normoxia

Experimental

Oxygen administration to maintain a hemoglobin oxygen saturation of 95-97% or arterial PaO2 80-110 mmHg during surgery.

干预措施: Oxygen - normoxia (Drug)

Hyperoxia

Active Comparator

Fraction of inspired oxygen 1.0 during mechanical ventilation and 0.8 during cardiopulmonary bypass during surgery.

干预措施: Oxygen - hyperoxia (Drug)

结局指标

主要结局

Intraoperative Systemic Oxidative Damage

时间窗: separation from cardiopulmonary bypass or completion of off-pump coronary artery bypass grafting (approximately 3-5 hours into surgery and intervention)

quantified by measuring F2-isoprostanes isofurans following separation from cardiopulmonary bypass or completion of off-pump coronary artery bypass grafting

Acute Kidney Injury

时间窗: baseline to postoperative day 2

quantified by change in serum creatinine concentration

次要结局

  • Vascular Reactivity / Endothelial Function (as Measured by Flow Mediated Dilation)(ICU admission (immediately after arrival in ICU from operating room))
  • Mitochondrial Function(up to 2 days following surgery)
  • Number of People With Arrhythmia(from surgery to hospital discharge, average of 6 days following surgery)
  • Myocardial Injury or Infarction(morning of postoperative day 1)
  • Number of People With Stroke(from surgery to hospital discharge, average of 6 days following surgery)
  • Postoperative Cognitive Dysfunction(up to 18 months following surgery)
  • Reactive Oxygen Species Production(end of surgery, defined as immediately after separation from cardiopulmonary bypass or completion of off-pump coronary artery bypass grafting (approximately 3-5 hours into surgery and intervention))
  • Acute Kidney Injury Estimated by Urine Concentration of NGAL(baseline to 2 days following surgery)
  • Oxygenation and Perfusion (Cerebral Oximetry)(continuously assessed throughout surgery and recorded each minute)
  • Vascular Reactivity / Endothelial Function (Tension Wire Myography, Endothelial Dependent Vasodilation, EC50)(tissue collected during surgery when heart is exposed approximately 2 hours into intervention)
  • Oxygenation and Perfusion (SpO2)(during surgery)
  • Oxygenation and Perfusion (PaO2)(end of surgery, defined as separation from cardiopulmonary bypass or completion of off-pump coronary artery bypass grafting (approximately 3-5 hours into surgery and intervention))
  • Vascular Reactivity / Endothelial Function (Peripheral Artery Tonometry)(ICU admission (immediately after arrival in ICU from operating room))
  • Respiratory Failure(from surgery to hospital discharge, average of 6 days following surgery)
  • Inflammation(up to 2 days following surgery)
  • Oxygenation and Perfusion (Lactate)(ICU admission (immediately after arrival in ICU from operating room))
  • Acute Kidney Injury, According to KDIGO Criteria(up to 7 days following surgery)
  • Acute Kidney Injury Estimated by Urine Concentration of TIMP-2 IGFBP7(baseline to 2 days following surgery)
  • Oxygenation and Perfusion (SvO2)(end of surgery, defined as following separation from cardiopulmonary bypass or completion of off-pump coronary artery bypass grafting (approximately 3-5 hours into surgery and intervention))
  • Vascular Reactivity / Endothelial Function (Tension Wire Myography, Endothelial Dependent Vasodilation, Emax)(tissue collected during surgery when heart is exposed approximately 2 hours into intervention)
  • Vascular Reactivity / Endothelial Function (Tension Wire Myography, Endothelial Independent Vasodilation, Emax)(tissue collected during surgery when heart is exposed approximately 2 hours into intervention)
  • Chronic Kidney Disease(12 months following surgery)
  • Acute Brain Dysfunction (Delirium)(from surgery to hospital discharge, average of 6 days following surgery)
  • Vascular Reactivity / Endothelial Function (Tension Wire Myography, Endothelial Independent Vasodilation, EC50)(tissue collected during surgery when heart is exposed approximately 2 hours into intervention)
  • Vascular Reactivity / Endothelial Function (Tension Wire Myography, sGC Activation Vasodilation, EC50)(tissue collected during surgery when heart is exposed approximately 2 hours into intervention)
  • Hemolysis(separation from cardiopulmonary bypass or completion of off-pump coronary artery bypass grafting (approximately 3-5 hours into surgery and intervention))
  • Oxygenation and Perfusion (Cardiac Index)(end of surgery, defined as immediately after separation from cardiopulmonary bypass or completion of off-pump coronary artery bypass grafting (approximately 3-5 hours into surgery and intervention))
  • Vascular Reactivity / Endothelial Function (Tension Wire Myography, sGC Activation Vasodilation, Emax)(tissue collected during surgery when heart is exposed approximately 2 hours into intervention)
  • Vascular Reactivity / Endothelial Function (PAI-1)(end of surgery, defined as immediately after separation from cardiopulmonary bypass or completion of off-pump coronary artery bypass grafting (approximately 3-5 hours into surgery and intervention))
  • Vascular Reactivity / Endothelial Function (E-selectin)(end of surgery, defined as immediately after separation from cardiopulmonary bypass or completion of off-pump coronary artery bypass grafting (approximately 3-5 hours into surgery and intervention))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Frederic T Billings IV

Assistant Professor of Anesthesiology

Vanderbilt University

研究点 (1)

Loading locations...

相似试验